Author: Royal Philips

Posted Date:

April 22, 2026

Philips receives FDA 510(k) clearance for its Rembra platform, expanding access to faster, more precise CT imaging across frontline care and cancer treatment planning

Royal Philips

April 22, 2026
Philips receives FDA 510(k) clearance for Verida, the world’s first AI-powered detector-based spectral CT*, advancing diagnostic precision across clinical applications

Royal Philips

April 16, 2026
MDIC appoints Philips Chief Medical Officer Carla Goulart Peron as new board member

Royal Philips

April 2, 2026
FDA clears Philips AI solution that provides real-time guidance during complex minimally invasive heart valve repair

Royal Philips

March 26, 2026
Philips launches IntraSight Plus to simplify coronary interventions and advance precision care

Royal Philips

March 25, 2026
Philips remains No. 1 in Medtech at European Patent Office and the largest Dutch patent applicant

Royal Philips

March 24, 2026
Philips convenes the Annual General Meeting of Shareholders 2026

Royal Philips

March 23, 2026
Philips proposes new appointment and re-appointments to its Supervisory Board and CEO re-appointment

Royal Philips

March 23, 2026
Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite

Royal Philips

March 11, 2026
Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26

Royal Philips

March 10, 2026